PHARMAQ Analytiq uses real-time RT-PCR, a molecular tool, to detect known viruses, bacteria and parasites in your samples.
Molecular data of this type is often used in combination with histological investigations and microbiology. Together, these data aid in the risk assessment of pathogen spread, and determination of the presence of house strains. Accurate and timeous data on gill and heart health can be very useful in informing decisions about planning treatments.
Continual monitoring of stock health facilitates early interventions should they be required.
PHARMAQ Analytiq provides real-time RT-PCR analyses for all known salmon, rainbow trout and lumpfish pathogens. In addition, we have developed assays for key pathogens known to infect sea bass, sea bream and tilapia. We are also constantly adding to our suite of analyses in response to and in cooperation with customers and their requirements.
PHARMAQ Analytiq is accredited to carry out a wide range of analyses. You can read more about our accreditation portfolio here.
Customers are encouraged to contact us in an early phase of the planning of a project. Our team can advise on sampling and study design in addition to relevant analyses, to optimize project setup and results.
Customer projectsPHARMAQ is the global leader in vaccines and innovation for aquaculture and part of Zoetis, the world leader in animal health. The company provides environmentally sound, safe and efficacious health products to the global aquaculture industry through targeted research and the commitment of dedicated people. Production facilities, administration and research and development activities are based in Norway with subsidiaries in Chile, United Kingdom, Vietnam, Turkey, Spain, Panama and Hong Kong. PHARMAQ has approximately 300 employees. The company's products are marketed in Europe, North and South America, and Asia. For further information, visit the company's website at www.pharmaq.com. Privacy Policy. Cookie Policy. Terms of Use.
Copyright © 2020 Zoetis LLC. All rights reserved.